Outlook Therapeutics Inc (OTLK)
8.43
+0.24
(+2.93%)
USD |
NASDAQ |
Apr 26, 16:00
8.42
-0.01
(-0.12%)
After-Hours: 20:00
Outlook Therapeutics Free Cash Flow: -47.10M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -47.10M |
| September 30, 2023 | -42.97M |
| June 30, 2023 | -40.48M |
| March 31, 2023 | -48.37M |
| December 31, 2022 | -54.59M |
| September 30, 2022 | -56.67M |
| June 30, 2022 | -55.41M |
| March 31, 2022 | -54.51M |
| December 31, 2021 | -51.92M |
| September 30, 2021 | -54.25M |
| June 30, 2021 | -57.34M |
| March 31, 2021 | -43.10M |
| December 31, 2020 | -38.44M |
| September 30, 2020 | -31.79M |
| June 30, 2020 | -25.65M |
| March 31, 2020 | -30.01M |
| December 31, 2019 | -29.18M |
| Date | Value |
|---|---|
| September 30, 2019 | -32.73M |
| June 30, 2019 | -36.44M |
| March 31, 2019 | -34.69M |
| December 31, 2018 | -36.09M |
| September 30, 2018 | -35.82M |
| June 30, 2018 | -26.11M |
| March 31, 2018 | -23.11M |
| December 31, 2017 | -19.55M |
| September 30, 2017 | -15.80M |
| June 30, 2017 | -26.55M |
| March 31, 2017 | -37.34M |
| December 31, 2016 | -40.19M |
| September 30, 2016 | -46.58M |
| June 30, 2016 | -50.19M |
| March 31, 2016 | -47.22M |
| December 31, 2015 | -44.46M |
| September 30, 2015 | -36.28M |
Free Cash Flow Range, Past 5 Years
-57.34M
Minimum
Jun 2021
-25.65M
Maximum
Jun 2020
-43.74M
Average
-43.10M
Median
Mar 2021
Free Cash Flow Benchmarks
| Cutera Inc | -160.13M |
| Actinium Pharmaceuticals Inc | -47.49M |
| GT Biopharma Inc | -8.852M |
| Karyopharm Therapeutics Inc | -92.72M |
| Marinus Pharmaceuticals Inc | -118.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.03M |
| Cash from Financing (Quarterly) | -0.0032M |
| Free Cash Flow Per Share (Quarterly) | -1.002 |
| Free Cash Flow Yield | -43.24% |